Accretion Pharmaceuticals Limited (NSE:ACCPL)
67.30
+3.20 (4.99%)
At close: Jan 22, 2026
Accretion Pharmaceuticals Revenue
Accretion Pharmaceuticals had revenue of 219.23M INR in the quarter ending September 30, 2025, with 136.00% growth. This brings the company's revenue in the last twelve months to 826.43M. In the fiscal year ending March 31, 2025, Accretion Pharmaceuticals had annual revenue of 573.76M with 329.70% growth.
Revenue (ttm)
826.43M
Revenue Growth
+329.70%
P/S Ratio
0.86
Revenue / Employee
6.61M
Employees
125
Market Cap
711.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 573.76M | 440.24M | 329.70% |
| Mar 31, 2024 | 133.53M | -161.79M | -54.79% |
| Mar 31, 2023 | 295.32M | 69.47M | 30.76% |
| Mar 31, 2022 | 225.84M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition